The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death
- PMID: 19399611
- DOI: 10.1007/s11064-009-9974-z
The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death
Abstract
Mutations in Cu/Zn superoxide dismutase are a cause of motor neuron death in about 20% of cases of familial amyotrophic lateral sclerosis (ALS). Although the molecular mechanism of which these mutations induce motor neuron cell death is to a large extent unknown, there is significant evidence that effects on mitochondrial function and development of oxidative stress make a major contribution to the selective death of motor neurons in this disease. In this overview article we review the current understanding of mutant SOD1-mediated motor neuron degeneration in ALS with focus on oxidative damage and mitochondrial dysfunction. We also present novel information on the role of mitochondrial glutathione for the survival of NSC-34 cells stably transfected with the human SOD1(G93A) mutation, putting forward the hypothesis that this antioxidant pool provides a potentially useful target for therapeutic intervention.
Similar articles
-
Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants.J Neurosci. 2008 Apr 16;28(16):4115-22. doi: 10.1523/JNEUROSCI.5308-07.2008. J Neurosci. 2008. PMID: 18417691 Free PMC article.
-
Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model.Neurobiol Dis. 2011 Sep;43(3):543-51. doi: 10.1016/j.nbd.2011.04.025. Epub 2011 May 6. Neurobiol Dis. 2011. PMID: 21600285 Free PMC article.
-
Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.Neurobiol Dis. 2000 Dec;7(6 Pt B):623-43. doi: 10.1006/nbdi.2000.0299. Neurobiol Dis. 2000. PMID: 11114261
-
Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS.J Bioenerg Biomembr. 2011 Dec;43(6):581-6. doi: 10.1007/s10863-011-9392-1. J Bioenerg Biomembr. 2011. PMID: 22089637 Free PMC article. Review.
-
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.Neurodegener Dis. 2004;1(6):245-54. doi: 10.1159/000085063. Neurodegener Dis. 2004. PMID: 16908975 Review.
Cited by
-
Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?Br J Pharmacol. 2014 Apr;171(8):2191-205. doi: 10.1111/bph.12476. Br J Pharmacol. 2014. PMID: 24148000 Free PMC article. Review.
-
The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease.Brain. 2014 Mar;137(Pt 3):668-82. doi: 10.1093/brain/awt371. Epub 2014 Jan 29. Brain. 2014. PMID: 24480485 Free PMC article.
-
Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection.PLoS One. 2011;6(5):e20354. doi: 10.1371/journal.pone.0020354. Epub 2011 May 31. PLoS One. 2011. PMID: 21655261 Free PMC article.
-
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients.Antioxidants (Basel). 2022 Apr 22;11(5):815. doi: 10.3390/antiox11050815. Antioxidants (Basel). 2022. PMID: 35624679 Free PMC article.
-
Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione.Free Radic Biol Med. 2012 Jan 15;52(2):410-9. doi: 10.1016/j.freeradbiomed.2011.10.495. Epub 2011 Nov 9. Free Radic Biol Med. 2012. PMID: 22115789 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous